Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,654,240
-$148,509 QoQ
Shares Held
10,451
-8.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.68%
of 13F equity value
Holder Rank
#2,099
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TIEMANN INVESTMENT ADVISORS, LLC holds $9,289,456 across 7 Drug Manufacturers - General names. JNJ ranks #1 (28.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
10,451 | $2,654,240 | |
| 2 | LLY |
ELI LILLY & Co
|
2,149 | $2,577,575 | |
| 3 | ABBV |
AbbVie Inc.
|
9,227 | $2,321,882 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,492 | $834,222 | |
| 5 | AMGN |
Amgen Inc
|
1,119 | $405,212 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,122 | $268,093 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,961 | $228,232 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,654,240 | 10,451 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,802,749 | 11,466 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,254,306 | 10,893 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,112,490 | 11,393 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,733,407 | 11,348 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,909,315 | 11,513 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,672,241 | 11,563 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,884,433 | 11,628 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,719,280 | 11,763 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,935,138 | 12,233 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,958,152 | 12,493 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,928,185 | 12,380 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,048,641 | 12,377 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,895,185 | 12,227 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,200,529 | 12,457 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,032,525 | 12,442 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,005,599 | 16,932 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,009,719 | 16,982 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,939,837 | 17,185 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,658,128 | 16,459 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,785,423 | 16,908 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,914,089 | 17,731 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,809,233 | 17,850 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,668,525 | 17,924 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,552,153 | 18,148 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,311,953 | 17,631 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||